Clinical Trials Logo

Clinical Trial Summary

The aim of the study was to evaluate the impact of inertial rehabilitation on: shoulder flexors, extensors and shoulder abductors and adductors strength, breast cancer-related lymphedema (BCRL) and quality of life in women after mastectomy. Twenty-four women after mastectomy were randomized to a training (T; n = 12) or control group (C; n = 12). The T group performed inertial training twice a week for 6 weeks using a Cyklotren inertial device. Each training session included warm-up and 4 sets of shoulder flexors, extensors, abductors, and adductors, with the right and left arms worked. The training loads for all exercises was equal 5 kg. Before and after training the maximum force of trained muscles was tested under training conditions. Body composition, BCRL, disabilities of the arm, shoulder and hand (DASH) were also evaluated. Inertial rehabilitation caused significant improvement in strength in all tested muscles in T whereas changes in C were insignificant. Quality of life evaluated by DASH score decreased significantly in T and and did not change in C. Moreover, BCRL and body composition did not change significantly following intervention in both groups. Inertial exercises can be useful rehabilitation method in women treated for breast cancer.


Clinical Trial Description

A group of 30 women who underwent mastectomy procedure attended an initial meeting and all of them agreed to participate in the study. The participants were members of an association of people after mastectomy (Amazons Association) and regularly participated in rehabilitation gymnastics twice a week for at least 3 years. All women met the including criteria: mastectomy was performed at least 6 months before the study, lack of: fractures in the prior 3 months, tendon and ligament injuries in the prior 2 months, serious heart disease, cerebral palsy, and limb amputations. All subjects received permission from their physician to participate in the experiment. Therefore, the study finally included 24 women after mastectomy (age, 66.2 ± 10.6 years, range 43-82 years; body mass, 72.7 ± 10.6 kg; height, 159 ± 5.2 cm), 17 after simple mastectomy and 7 after breast conserving therapy. The participants were randomly allocated into two groups: a training group (T; n = 12) and a control group (C; n = 12) using chit method. The T group participated in 6 weeks of inertial training while the control group maintain their normal daily activity. All women still participated in rehabilitation gymnastics twice a week. All participants gave written informed consent to take part in the study. Testing Before and after training participants were evaluated using the following tests: - strength of shoulder muscles measurements - body composition measurements - breast cancer-related lymphedema (BCRL) evaluation - disabilities of the arm, shoulder and hand test (DASH) Strength of shoulder muscles measurement. Strength of shoulder flexors and extensors and strength of shoulder abductors and adductors were tested in the standing position using Cyklotren inertial device (Naczk 2015). After warm-up, each participant performed a 10-second maximal test of the right and left arm separately, with a 2-minute break between measurements. Participants position during strength testing and inertial training is showed on Figure1. For all measurement 5 kg load was applied. It should be noted here that the same load during inertial training doesn't mean the working muscles develop the same force. During inertial exercise force developed by muscle strongly depend on movement velocity, greater movement velocity results greater muscle load and greater force is developed (the force value is presented on-line on the Cyklotren's screen). The range of motion was approximately 90 degree (where 0 degrees corresponded to the arm along the trunk). Data collection was preceded by a familiarization session. Body composition measurements Bioelectric impedance were used to evaluate the body composition of participants (Tanita 980 MC, Japan). The participants were asked to maintain a normal state of hydration, and they were not allowed to exercise, eat, or drink alcohol or caffeine for 12 h preceding the measurements. Measurements were conducted in the morning according to the manufacturer's guidelines. Fat mass, muscle mass, amount of water were used in future analyses. Breast cancer-related lymphedema evaluation To evaluate the influence of inertial rehabilitation on breast cancer-related lymphedema bioimpedance spectroscopy was used. This technique allows to detect small changes in extracellular fluid (ECF) and subclinical BCRL, therefore allows for the subclinical detection of BCRL when visible swelling is not apparent. Measurements were done using L-Dex U400 unit (ImpediMed Limited, Australia). The feasibility and clinical utility of implementing L-Dex measurements in routine breast cancer care was confirmed in previous studies (Laidley and Anglin 2016, Kilgore et al 2018). During the measurements patients were lying supine on a non-metallic surface a standardized technique according to Laidley and Anglin (2016) methodology. Disabilities of the arm, shoulder and hand test (DASH) To evaluate ability of the participants do the different daily activities DASH questionnaire was completed. DASH questionnaire is a standardized measure which captures the patients' own perspective of their upper extremity health status (Jester et. al 2005). During the questionnaire completing subjects were provided with conditions that allowed them to mark the answers freely. Workout Inertial rehabilitation was performed twice a week (Monday and Thursday, between 5:00 and 8:00 PM) for 6 weeks using Cyklotren device (Inerion, Poland). Exercises were conducted by the same 2 researchers. Each training session included warm-up and 4 sets of shoulder flexors, extensors, abductors, and adductors, with the right and left arms worked separately (16 sets for left and 16 sets for right arm). Each set lasted 15 seconds, a 2-minute break occurred between consecutive sets (without rest period between right and left arm). For all trained muscles 5 kg load was applied. During the training participants developed 70% of their maximal force achieved during the strength measurement. Participants observed developed during training force value displayed on-line on the screen. Cyklotren software allows to set the upper and lower limit of force; when developed strength was to low or to high a beep signal was emitted to correct participant force. Statistical analysis Normality of distribution of the data was tested using the Shapiro-Wilk method. Descriptive statistics, including means and standard deviations, were calculated. For testing significance of changes analysis of variance (ANOVA) were used. The simple effect of training for each participant was defined as a relative increase in an analyzed variable after training compared with the before-training value.Lower and upper borders of 95% confidence intervals for relative increase were calculated. Differences in relative increases between groups were tested with one-way ANOVA. If differences were detected, the Scheffé post hoc procedure was used to determine where the differences occurred. The level of significance was set at P ≤ 0.05. The effect size (ES) of the training was calculated using the paired two-sample t-test, and according to Goulet-Pelletiera and Cousineaua (2018) Cohen's d with Hedges g correction was determined. The scale presented by Cohen indicates that d < 0.41 represents a small ES, 0.41-0.70 a moderate ES, and higher than 0.70 a large ES. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04621942
Study type Interventional
Source University in Zielona Góra
Contact
Status Completed
Phase N/A
Start date April 2, 2019
Completion date July 24, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Recruiting NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Recruiting NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A